Long-term Outcome Reporting in Older Kidney Transplant Recipients and the Limitations of Conventional Survival Metrics

被引:2
|
作者
Vanhove, Thomas [1 ,2 ]
Elias, Nahel [3 ]
Safa, Kassem [1 ]
Cohen-Bucay, Abraham [1 ]
Schold, Jesse D. [4 ]
Riella, Leonardo V. [1 ]
Gilligan, Hannah [1 ]
机构
[1] Harvard Med Sch, Massachusetts Gen Hosp, Div Renal, Boston, MA USA
[2] Ctr Hosp Luxembourg, Dept Nephrol, Luxembourg, Luxembourg
[3] Massachusetts Gen Hosp, Dept Surg & Transplant Ctr, Boston, MA USA
[4] Cleveland Clin, Dept Quantitat Hlth Sci, Ctr Populat Hlth Res, Cleveland, OH USA
来源
KIDNEY INTERNATIONAL REPORTS | 2022年 / 7卷 / 11期
关键词
competing risk; elderly; graft failure; kidney transplantation; multistate models; survival analysis; RENAL-TRANSPLANTATION; FAILURE; MORTALITY; DIALYSIS; REGISTRY; DEATH; AGE;
D O I
10.1016/j.ekir.2022.08.010
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction: The kidney transplant recipient population in the United States is aging rapidly, which may exacerbate some of the limitations of conventional outcome metrics. Methods: Using data from the Scientific Registry of Transplant Recipients (SRTR), age-stratified unadjusted Kaplan-Meier and competing risk survival analyses were performed on a cohort of 238,123 adult recipients of a first-time single kidney transplant between 2000 and 2017. These were compared with a multistate model incorporating 5 post-transplant states (alive with functioning graft, death with functioning graft, graft failed (alive), retransplanted, and death after graft failure). Results: Kaplan-Meier resulted in an age-dependent overestimation of the risks of graft failure and death with functioning graft, compared with competing risk or multistate models. In elderly (>= 75 years old) recipients, the absolute overestimation of the risk of death with functioning graft was 4-fold higher than in those younger than 55 years. The multistate model demonstrated that for patients transplanted at age 55 years and older, the probability of being back on dialysis was never more than 4% at any point post-transplant. The underlying reasons were low graft failure rates and high mortality after resuming dialysis as follows: 2-year mortality after graft failure was 38%, 54%, and 67% in recipients aged from 55 to 64 years, from 65 to 74 years, and those aged 75 years and older, versus 20% in those younger than 55 years. Conclusion: Multistate models provide an accurate and comprehensive assessment of the life course of kidney transplant recipients. This may be particularly relevant in older recipients, who are more prone to event rate overestimation and for whom outcomes after graft failure are substantially worse than for younger recipients.
引用
收藏
页码:2397 / 2409
页数:13
相关论文
共 50 条
  • [31] The Long-Term Outcome of Ketoconazole and Tacrolimus Co-Administration in Kidney Transplant Recipients.
    Killackey, M.
    Khan, E.
    Liu, Y.
    Kumbala, D.
    LaGuardia, H.
    Paramesh, A.
    Slakey, D.
    Saggi, B.
    Buell, J.
    Zhang, R.
    TRANSPLANTATION, 2014, 98 : 465 - 465
  • [32] Long-Term Survival Analysis of Kidney Transplant Recipients Receiving Mizoribine as a Maintenance Immunosuppressant.
    Kim, J.
    Lee, D.
    Oh, J.
    Lee, J.
    Kim, H.
    Son, Y.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 698 - 698
  • [33] HYPERTENSION IN KIDNEY-TRANSPLANT RECIPIENTS - EFFECT ON LONG-TERM RENAL-ALLOGRAFT SURVIVAL
    CHEIGH, JS
    HASCHEMEYER, RH
    WANG, JCL
    RIGGIO, RR
    TAPIA, L
    STENZEL, KH
    RUBIN, AL
    AMERICAN JOURNAL OF HYPERTENSION, 1989, 2 (05) : 341 - 348
  • [34] HYPERTENSION (H) AND DECREASED GRAFT-SURVIVAL IN LONG-TERM KIDNEY-TRANSPLANT RECIPIENTS
    CHEIGH, JS
    WANG, J
    FINE, P
    RIGGIO, RR
    TAPIA, L
    RUBIN, AL
    STENZEL, KH
    KIDNEY INTERNATIONAL, 1985, 27 (01) : 188 - 188
  • [35] Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival
    Pretagostini, R.
    Cinti, P.
    Lai, Q.
    Poli, L.
    Berloco, P. B.
    TRANSPLANT IMMUNOLOGY, 2008, 20 (1-2) : 3 - 5
  • [36] Long-Term Outcomes of Kidney Transplant Recipients With Juvenile Nephronophthisis
    Avci, Begum
    Baskin, Esra
    Gulleroglu, Kaan
    Yilmaz, Aysun Caltik
    Kantar, Asli
    Akdur, Aydincan
    Moray, Gokhan
    Haberal, Mehmet
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2022, 20 (05) : 122 - 125
  • [37] Serum Bicarbonate and Long-Term Outcomes in Kidney Transplant Recipients
    Park, S.
    Kang, E.
    Han, M.
    Park, J.
    Yang, S.
    Park, S.
    Jung, I.
    Lim, C.
    Kim, Y.
    Kim, Y.
    Lee, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 324 - 324
  • [38] Bisphosphonates and bone fractures in long-term kidney transplant recipients
    Conley, Emily
    Muth, Brenda
    Samaniego, Millie
    Lotfi, Mary
    Voss, Barbara
    Armbrust, Mike
    Pirsch, John
    Djamali, Arjang
    TRANSPLANTATION, 2008, 86 (02) : 231 - 237
  • [39] Decreased Long-Term Survival with Antithymocyte Globulin Induction in Elderly Kidney Transplant Recipients.
    Bajjoka, I.
    Yaldo, A.
    Crombez, C.
    Abouljoud, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 329 - 329
  • [40] Pretransplant PRA and Long-Term Outcomes of Kidney Transplant Recipients
    Huber, L.
    Niemann, M.
    Lachmann, N.
    Naik, M.
    Schoenemann, C.
    Schmidt, D.
    Liefeldt, L.
    Glander, P.
    Neumayer, H. H.
    Budde, K.
    TRANSPLANTATION, 2012, 94 (10) : 1076 - 1076